ABCL: AbCellera Biologics Inc. Stock

by  •  • Comments Off on ABCL: AbCellera Biologics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 948.13
Enterprise Value ($M) 821.49
Book Value ($M) 1,078.09
Book Value / Share 3.65
Price / Book 0.88
NCAV ($M) 428.15
NCAV / Share 1.45
Price / NCAV 2.21

Profitability (mra)
Return on Invested Capital (ROIC) -0.15
Return on Assets (ROA) -0.12
Return on Equity (ROE) -0.15

Liquidity (mrq)
Quick Ratio 9.34
Current Ratio 9.34

Balance Sheet (mrq) ($M)
Current Assets 742.88
Assets 1,392.83
Liabilities 314.73
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Baker Bros. Advisors Lp 9.30 20.15
10-09 13G/A Baillie Gifford & Co
02-13 13G/A Hansen Carl L. G. 20.60 2.96

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-02-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-05 1,089,383 4,297,709 25.35
2025-02-04 561,038 2,204,051 25.45
2025-02-03 1,516,559 4,357,464 34.80
2025-01-31 788,202 3,028,069 26.03

(click for more detail)

Similar Companies
ABOS – Acumen Pharmaceuticals, Inc. ABUS – Arbutus Biopharma Corporation


Financial data and stock pages provided by
Fintel.io

Finpedia: AbCellera Biologics